DH001 tablets

· Monyan Pharmaceutical (Shanghai) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DH001 tablets, covering 2023-10-23 to 2023-10-23. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients [Phase 2]

See pricing